Clinical and Translational Science Workforce Development through a Statewide Community College Partnership

通过全州社区学院合作伙伴关系进行临床和转化科学劳动力发展

基本信息

项目摘要

Summary This R25 Research Education Module, leveraging the infrastructure of the Indiana Clinical and Translational Sciences Institute (I-CTSI), will foster development of a diverse clinical and translational workforce within Indiana through education and immersive experiences of learners from historically marginalized backgrounds enrolled in Ivy Tech, our statewide community college system. The clinical and translational science workforce is lacking diversity. This has profound negative consequences across the translational spectrum. There is strong evidence that career exposure and experiences have a positive impact on career choices. Ivy Tech is the largest singly accredited statewide community college system in the country, with campuses across Indiana and an undergraduate enrollment of ~120,000. Over half of all the Black/African American or Hispanic/Latinx undergraduate learners in the Indiana public education undergraduate system attend Ivy Tech. The numerous majors at Ivy Tech that have connections to clinical and translational research make this an ideal platform to engage learners into these careers. Herein, we propose to combine career exploration with an immersion research experience to help learners develop a pathway toward the clinical and translational science workforce. Our program has three components. The first (AIM 1), focused on broad exposure to learners about careers in clinical and translational science, will be achieved through synchronous virtual programming across the statewide Ivy Tech system. The second (AIM 2a), focused on immersion research experiences, will connect learners, termed CTSI-Scholars from Ivy Tech campuses near one of the four University campuses of our I-CTSI (Notre Dame, Purdue, Indiana-Bloomington, and Indiana-Indianapolis) into a 10-week summer experience. These Universities each have thematic foci of clinical and translational research/science that will serve as primary research experiences. The program will prioritize learners from historically marginalized populations as CTSI/Ivy Tech Scholars. The third program component (AIM 2b), will provide support through a cohort-based longitudinal mentoring/professional development, focused on career-pathway attainment over the subsequent year. The program's efficacy will be determined (AIM 3) through evaluation of learner progression into educational tracks/careers connected to clinical and translational science. The Overall proposal is led by a Multi- PI team, who serve as co-Directors of Workforce Development program in the I-CTSI. They bring complementary expertise to the leadership and are supported by an Advisory Committee of leaders at Ivy Tech and the I-CTSI as well as numerous program staff from both entities.
总结 该R25研究教育模块利用了印第安纳州临床和翻译中心的基础设施, 科学研究所(I-CTSI),将促进印第安纳州内多样化的临床和翻译工作队伍的发展 通过来自历史边缘化背景的学习者的教育和沉浸式体验, 常春藤科技,我们全州的社区大学系统临床和转化科学的劳动力缺乏 多样性这在整个翻译谱中具有深远的负面影响。有强有力的证据 职业接触和经历对职业选择有积极的影响。常春藤科技是最大的 认证的全州社区学院系统在该国,校园遍布印第安纳州和一个 本科招生约12万人。超过一半的黑人/非洲裔美国人或西班牙裔/拉丁裔 印第安纳州公共教育本科系统的本科学生就读于常春藤理工学院。的众多 常春藤理工学院的专业与临床和转化研究有关,这是一个理想的平台, 让学习者参与到这些职业中来。在此,我们建议将联合收割机职业探索与沉浸式学习相结合 研究经验,以帮助学习者发展走向临床和转化科学劳动力的途径。 我们的计划有三个组成部分。第一个(AIM 1),侧重于广泛接触学习者的职业生涯, 临床和转化科学,将通过同步虚拟编程实现跨 全州范围的常春藤科技系统第二个(AIM 2a),专注于沉浸式研究体验,将连接 学生,被称为CTSI学者从常春藤科技校园附近的四个大学校园之一,我们的I-CTSI (圣母院,普渡大学,印第安纳布卢明顿和印第安纳印第安纳波利斯)到一个为期10周的夏季经验。 这些大学都有临床和转化研究/科学的主题焦点,将作为 主要研究经验。该计划将优先考虑来自历史上边缘化人口的学习者, CTSI/Ivy Tech学者。第三个计划组件(AIM 2b)将通过基于队列的支持提供支持 纵向指导/专业发展,重点是在随后的职业道路上实现 年该计划的功效将通过评估学习者的进展来确定(AIM 3), 与临床和转化科学相关的教育轨道/职业。总体建议由一个多- PI团队,他们担任I-CTSI劳动力发展计划的联合主任。它们带来了互补性 专业知识的领导,并得到咨询委员会的领导人在常春藤科技和I-CTSI的支持 以及来自两个实体的众多项目工作人员。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew R Allen其他文献

Matthew R Allen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew R Allen', 18)}}的其他基金

Precision medicine approaches to renal osteodystrophy
肾性骨营养不良症的精准医学方法
  • 批准号:
    10685341
  • 财政年份:
    2022
  • 资助金额:
    $ 10.8万
  • 项目类别:
Precision medicine approaches to renal osteodystrophy
肾性骨营养不良症的精准医学方法
  • 批准号:
    10539650
  • 财政年份:
    2022
  • 资助金额:
    $ 10.8万
  • 项目类别:
Treating bone deterioration associated with chronic kidney disease
治疗与慢性肾病相关的骨质恶化
  • 批准号:
    10343760
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.
慢性肾脏病中骨质量和力学受损的发病机制。
  • 批准号:
    9751842
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Treating bone deterioration associated with chronic kidney disease
治疗与慢性肾病相关的骨质恶化
  • 批准号:
    9142786
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Treating bone deterioration associated with chronic kidney disease
治疗与慢性肾病相关的骨质恶化
  • 批准号:
    10554260
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Enhancing bone strength using combination drug therapy
使用联合药物疗法增强骨强度
  • 批准号:
    8303617
  • 财政年份:
    2012
  • 资助金额:
    $ 10.8万
  • 项目类别:
Enhancing bone strength using combination drug therapy
使用联合药物疗法增强骨强度
  • 批准号:
    9012010
  • 财政年份:
    2012
  • 资助金额:
    $ 10.8万
  • 项目类别:
Enhancing bone strength using combination drug therapy
使用联合药物疗法增强骨强度
  • 批准号:
    8581777
  • 财政年份:
    2012
  • 资助金额:
    $ 10.8万
  • 项目类别:
Enhancing bone strength using combination drug therapy
使用联合药物疗法增强骨强度
  • 批准号:
    8825726
  • 财政年份:
    2012
  • 资助金额:
    $ 10.8万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 10.8万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了